UNT Health Science Center's Groundbreaking Research Applied to Protecting Brain After Traumatic Injury
Posted on: Friday, 3 July 2009, 11:02 CDT
James Simpkins, Ph.D., UNT Health Science Center chair of the Department of Pharmacology and Neuroscience, and Jane Wigginton, M.D., Department of Surgery, Division of Emergency Medicine at UT Southwestern Medical Center of
"Our animal research has demonstrated that rapid estrogen intervention protects the brain following injury, including stroke or sudden cardiac arrest," Simpkins said. "Now, UT Southwestern and Parkland Health and Hospital System are advancing our research from the UNT Health Science Center to these studies in human subjects. If we can administer these drugs to trauma victims very early, I believe that we can protect the brain and increase survival."
Simpkins' studies in animals found that rapidly administering a single dose of estrogen, a strong anti-oxidant and an anti-inflammatory drug, following a stroke increases brain cell survival by up to 65 percent. Estrogens delivered intravenously post injury may have similar effects on people with traumatic brain injury. "We know these substances can protect the brain and believe them safe for use in this patient population," Simpkins said.
The clinical trials are based on now hundreds of scientific publications from Simpkins' group and others demonstrating the protective effects of estrogens in acute brain injury. Simpkins leads a large National Institutes of Health-funded program of research to discover substances that can protect the brain from injury. This is the first major clinical study to emanate from these basic science studies at the
Estrogens are made in large amounts by young women, but only in small amounts by men. Prior studies have suggested that young women are more resistant to brain trauma injury than are older, post-menopausal women and men. This apparent resistance of young women to brain trauma may be because of their higher estrogen levels. These current studies of the effects of rapid estrogen administration on patients with traumatic brain injury and hemorrhagic shock will be a test of this proposal.
In 1994, Simpkins discovered that estrogens were protective to nerve cells and subsequently has demonstrated that, if administered soon after brain injury in animals, estrogens can protect nerve cells and reduce neurological deficits. Application of these discoveries to human subjects awaited the interactions of Simpkins with the pioneering clinical research of Wigginton, who is now the first to take estrogens into clinical trials for acute brain injury and hemorrhagic shock.
University of North
The
SOURCE
Source: PR Newswire
Related Articles
- Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business
- Posit Science Provides Free Brain Health Tips and Tools in Celebration of Brain Awareness Week
- Press Conference Invitation: Health Workforce Information Center (HWIC) Launch
- Scientists Reveal Roadmap to Brain Health That Can Be Passed Down to Future Generations: Exercise, Omega-3, Folic Acid, Vitamin B6, and Vitamin B12
- Brain Health Leaders Team Up to Prevent Crashes
- Health Net Call Center, Supporting the TRICARE North Region, Receives J.D. Power and Associates Certification
- Life Time Fitness to Bring Distinctive and Large Health and Fitness Center to Sugarloaf, Georgia
- Consumer-Led Revolution in Brain Health Catches Doctors By Surprise
- Public Health Asks of Systems Science: To Advance Our Evidence- Based Practice, Can You Help Us Get More Practice-Based Evidence?
- Centered on Education Research
User Comments (0)

RSS Feeds